[1]
M. Stefaniak, Z. Pietrzak, P. Dzikowski, E. Nowicka, M. Obel, and H. Piecewicz-Szczęsna, “Eslicarbazepine acetate: An efficacy and safety as an antiepileptic drug in clinical trials and open studies”, J Educ Health Sport, vol. 12, no. 2, pp. 16–26, Feb. 2022.